FDA has announced Acclarent has initiated a recall of its Inspira AIR Balloon Dilation System, size 18x40mm, product code BC1840A, manufactured between March 2011 and June 2011, according to an FDA ...
Integra LifeSciences Holding Corporation has announced the enrollment of the first patient in the Acclarent AERA Pediatric Registry, which aims to evaluate the real-world use of the AERA Eustachian ...
New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualization capabilities during sinus surgery for the treatment of chronic rhinosinusitis. Since 2005, more ...
Acclarent AERA® Eustachian Tube Balloon Dilation System First Patient Enrolled in Acclarent AERA® Pediatric Registry The articles, information, and content displayed on this webpage may include ...
Acclarent, a maker of a device for sinus treatments, has raised $35 million in a third round of funding, VentureWire reports (sub required): Acclarent, based in Menlo Park, Calif., was founded in June ...
Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat (ENT) technologies, has received clearance from the U.S.
Integra LifeSciences Holdings Corp. is seeking to establish itself in the ear, nose and throat category with its acquisition of Acclarent Inc. The Princeton-based medical technology company announced ...
Acclarent, a subsidiary of Johnson & Johnson ($JNJ), received FDA de novo clearance to begin marketing its Aera eustachian tube balloon dilation system developed to ...
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback